Work Experience
2008/09 - 2012/06, Shandong First Medical University, Biology engineering, Bachelor.
2012/09 - 2015/06, Lanzhou university, School of basic medical sciences, Genetics, Master.
2015/09 - 2017/06, Affiliated Hospital of Qinghai University, Clinical laboratory.
2017/06 - 2018/08, Chinese Academy of Agricultural Sciences, Innovative drug laboratory, Research assistant.
2018/09 - 2022/01, Fudan university, School of Life Sciences, Genetics, Doctor of Science.
2022/01 – Present, Fudan university, Human Phenogroup Research Institute,Postdoctoral fellow.
Research Interests
Study on the molecular mechanism of skin and pulmonary fibrosis in scleroderma
Awards
1. Excellent Student Leader of Shandong First Medical University.
2. First-class scholarship of Lanzhou University.
3. Excellent Worker Award of Chinese Academy of Agricultural Sciences.
4. National Natural Science Foundation of China, 82030003, The Role and molecular mechanism of iron metabolism disorder in pulmonary fibrosis, 2021-01-2025-12. 2,960,000 Yuan, In progress, Participation.
Selected Publications
1. Jiaoqin Shou#, Xiangzhen Kong#, Xiaoyang Wang, Ying Tang, Chunmei Wang, Mi Wang, Lifang Zhang, Yingchun Liu, Chenzhong Fei, Feiqun Xue, Juan Li, Keyu Zhang. Tizoxanide Inhibits Inflammation in LPS-Activated RAW264.7 Macrophages via the Suppression of NF-κB and MAPK Activation. Inflammation. 2019 Aug;42(4):1336-1349.
2. Kong X, Li Z, Li X. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis. Cancer Chemother Pharmacol. 2016 Dec;78(6):1163-1173.
